BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 952 filers reported holding BAXTER INTL INC in Q1 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,161,185 | -51.4% | 30,768 | -41.4% | 0.00% | -50.0% |
Q2 2023 | $2,390,715 | +21.7% | 52,474 | +8.3% | 0.00% | 0.0% |
Q1 2023 | $1,964,646 | -15.2% | 48,438 | +6.6% | 0.00% | 0.0% |
Q4 2022 | $2,317,046 | -27.5% | 45,459 | -23.2% | 0.00% | -33.3% |
Q3 2022 | $3,196,000 | -19.7% | 59,227 | -4.4% | 0.00% | -25.0% |
Q2 2022 | $3,982,000 | -96.9% | 61,977 | -96.2% | 0.00% | -96.3% |
Q1 2022 | $128,029,000 | +2068.1% | 1,650,719 | +2202.6% | 0.11% | +2060.0% |
Q4 2021 | $5,905,000 | +27.9% | 71,690 | +21.8% | 0.01% | +25.0% |
Q3 2021 | $4,618,000 | -20.8% | 58,876 | -21.7% | 0.00% | -20.0% |
Q2 2021 | $5,832,000 | -85.3% | 75,178 | -84.1% | 0.01% | -86.8% |
Q1 2021 | $39,646,000 | -55.2% | 471,861 | -57.2% | 0.04% | -58.7% |
Q4 2020 | $88,528,000 | +4.2% | 1,103,718 | +4.4% | 0.09% | -8.9% |
Q3 2020 | $84,962,000 | -4.8% | 1,056,874 | +2.0% | 0.10% | -9.0% |
Q2 2020 | $89,222,000 | +12.2% | 1,036,646 | +5.8% | 0.11% | -8.3% |
Q1 2020 | $79,524,000 | +178.3% | 979,490 | +186.6% | 0.12% | +266.7% |
Q4 2019 | $28,577,000 | -48.7% | 341,746 | -46.3% | 0.03% | -51.5% |
Q3 2019 | $55,681,000 | -11.3% | 636,572 | -17.0% | 0.07% | -9.3% |
Q2 2019 | $62,780,000 | +58.0% | 766,538 | +56.9% | 0.08% | +53.1% |
Q1 2019 | $39,728,000 | +171.3% | 488,603 | +119.6% | 0.05% | +145.0% |
Q4 2018 | $14,645,000 | +262.5% | 222,505 | +324.7% | 0.02% | +300.0% |
Q3 2018 | $4,040,000 | -38.5% | 52,397 | -40.2% | 0.01% | -28.6% |
Q2 2018 | $6,572,000 | +55.4% | 87,563 | +37.3% | 0.01% | +40.0% |
Q1 2018 | $4,230,000 | -4.5% | 63,798 | -4.3% | 0.01% | 0.0% |
Q4 2017 | $4,428,000 | +26.2% | 66,630 | +19.1% | 0.01% | +25.0% |
Q3 2017 | $3,510,000 | +9.0% | 55,935 | +5.2% | 0.00% | 0.0% |
Q2 2017 | $3,220,000 | +23.1% | 53,180 | +5.4% | 0.00% | +33.3% |
Q1 2017 | $2,616,000 | +25.8% | 50,441 | +7.6% | 0.00% | 0.0% |
Q4 2016 | $2,079,000 | -10.2% | 46,876 | -3.7% | 0.00% | 0.0% |
Q3 2016 | $2,316,000 | +192.4% | 48,665 | +177.9% | 0.00% | +200.0% |
Q2 2016 | $792,000 | +62.0% | 17,513 | +47.2% | 0.00% | 0.0% |
Q1 2016 | $489,000 | -0.6% | 11,894 | -7.8% | 0.00% | 0.0% |
Q4 2015 | $492,000 | -65.5% | 12,900 | -70.3% | 0.00% | -50.0% |
Q3 2015 | $1,426,000 | -64.9% | 43,422 | -25.3% | 0.00% | -60.0% |
Q2 2015 | $4,067,000 | -0.5% | 58,162 | -2.5% | 0.01% | +25.0% |
Q1 2015 | $4,086,000 | -6.0% | 59,656 | +0.6% | 0.00% | -20.0% |
Q4 2014 | $4,346,000 | -72.5% | 59,308 | -73.1% | 0.01% | -68.8% |
Q3 2014 | $15,802,000 | +237.3% | 220,177 | +239.8% | 0.02% | +220.0% |
Q2 2014 | $4,685,000 | -6.9% | 64,800 | -5.2% | 0.01% | 0.0% |
Q1 2014 | $5,030,000 | -94.7% | 68,364 | -95.0% | 0.01% | -94.8% |
Q4 2013 | $94,564,000 | -67.7% | 1,359,650 | -70.8% | 0.10% | -44.6% |
Q3 2013 | $293,029,000 | +63.8% | 4,652,053 | +80.1% | 0.18% | -17.8% |
Q2 2013 | $178,879,000 | – | 2,582,350 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |